Penticton Regional Hospital is a 140-bed hospital located in Penticton, British Columbia. It is operated by Interior Health and affiliated with UBC Faculty of Medicine. Penticton Regional Hospital was incorporated in 1913.

There are 140 beds in Penticton Regional Hospital.

During the past decade, Penticton Regional Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penticton Regional Hospital" #1 sponsor was "NCIC Clinical Trials Group" with 9 trials, followed by "AGO Study Group" with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Canadian Immunization Research Network" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penticton Regional Hospital" #1 collaborator was "Cancer and Leukemia Group B" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "National Cancer Institute (NCI)" with 3 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Penticton Regional Hospital" are "Breast Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Acute Ischemic Stroke" (1 trials), "Breast Adenocarcinoma" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Penticton Regional Hospital" in a lesser frequency.

Most popular intervention types in "Penticton Regional Hospital" are "Drug" (15 trials), "Other" (4 trials), "Procedure" (3 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Exemestane" (2 trials), "Laboratory Biomarker Analysis" (2 trials), "Quality-of-Life Assessment" (2 trials), "Radiation Therapy" (2 trials) and "alvocidib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Penticton Regional Hospital" are 10 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Penticton Regional Hospital". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Penticton Regional Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Penticton Regional Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".